EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE
Skip to content
Search:
About us
Contact us
Superior MPE
Myeloma Patients Europe
Myeloma and AL Amyloidosis
Multiple Myeloma
About AL amyloidosis
What we do
Member and patient community programmes
MPE Masterclass
Scholarship programme
Myeloma CABs
MPE Myeloma and AL amyloidosis Community Taskforce
Advocate Development Programme
Reasonable Agreements between Patient Advocates and Pharmaceutical Companies (RAPP)
COVID-19
Research
Patient Evidence
Horizon Europe
IMI
Access
Access to myeloma treatment
CEE workgroup on Access
Myeloma Trial Navigator
Educational resources
Educational clips
Webinars
Q&As
Toolkits
Factsheets
Conference reports
Patient guides
European Myeloma Day
News
Privacy Policy
Cookies Policy
Facebook page opens in new window
Twitter page opens in new window
YouTube page opens in new window
Linkedin page opens in new window
EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE
About MPE
Our members
Our board and staff
Medical Advisory Commitee
Our funding
Get involved in MPE activities
Become a MPE member
Contact us
Myeloma and AL Amyloidosis
About myeloma
What is myeloma?
What causes myeloma?
Coping with a myeloma diagnosis
Early diagnosis and smoldering myeloma
Diagnostic tests
Treatment of myeloma
Myeloma symptoms and treatment side-effects
Caring for yourself
Dealing with the psycho-social aspects of the disease
Managing myeloma and work, finance and advance decisions
Myeloma landscape and future directions
Clinical trials
Finding out about myeloma clinical trials
About AL amyloidosis
Symptoms of AL amyloidosis
AL amyloidosis diagnosis
AL amyloidosis treatment
Living with AL amyloidosis
AL amyloidosis: caring for yourself
AL amyloidosis treatment side effects
Socio-economical impact
Advance decisions
Novel treatment options in AL amyloidosis
AL amyloidosis clinical trials
What we do
Member and patient community programmes
MPE Masterclass
Scholarship programme
Myeloma CABs
MPE Myeloma and AL amyloidosis Community Taskforce
Advocate Development Programme
COVID-19
Reasonable Agreements between Patient Advocates and Pharmaceutical Companies (RAPP)
Research
Patient Evidence
Horizon Europe
MMPredict
CARAMBA
IMI
Harmony
Sisaqol
Access
Access to myeloma treatment
CEE workgroup on Access
Myeloma and AL Amyloidosis Trial Navigator
Educational resources
Educational clips
Webinars
Q&As
Toolkits
Factsheets
Conference reports
Patient guides
News
European Myeloma Day
European Myeloma Day | Learn
European Myeloma Day | Share
European Myeloma Day | Change
Myeloma infographics
AL amyloidosis infographics
Videos
Involvement in MPE activities: registration for interested individuals
You are here:
Home
Involvement in MPE activities: registration…
Name
*
First
Last
Email
*
Country
*
Afghanistan
Albania
Algeria
Andorra
Angola
Antigua & Deps
Argentina
Armenia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bhutan
Bolivia
Bosnia Herzegovina
Botswana
Brazil
Brunei
Bulgaria
Burkina
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Central African Rep
Chad
Chile
China
Colombia
Comoros
Congo
Congo {Democratic Rep}
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Fiji
Finland
France
Gabon
Gambia
Georgia
Germany
Ghana
Greece
Grenada
Guatemala
Guinea
Guinea-Bissau
Guyana
Haiti
Honduras
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland {Republic}
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Korea North
Korea South
Kosovo
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Mauritania
Mauritius
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Morocco
Mozambique
Myanmar, {Burma}
Namibia
Nauru
Nepal
Netherlands
New Zealand
Nicaragua
Niger
Nigeria
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Rwanda
St Kitts & Nevis
St Lucia
Saint Vincent & the Grenadines
Samoa
San Marino
Sao Tome & Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Togo
Tonga
Trinidad & Tobago
Tunisia
Turkey
Turkmenistan
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Uzbekistan
Vanuatu
Vatican City
Venezuela
Vietnam
Yemen
Zambia
Zimbabwe
I am (check all that apply)
*
Myeloma patient
AL amyloidosis patient
Myeloma carer
AL amyloidosis carer
Patient advocate
Healthcare Professional
Other
*
Please tell us more below – if you have specific background or skills in areas such as medical writing, graphic design or other ways in which you’d like to help MPE, please tell us more about this!
Interest in MPE activities
Areas of interest (check all that apply)
*
Surveys around treatments, trials or around patient preferences
Reviewing materials designed for patients
Developing materials designed for patients
Workgroups, tasks or activities relating to Patient Engagement
Workgroup, tasks or activities relating to Clinical Research & Development
Workgroup, tasks or activities relating to Access to clinical trials and treatment
Myeloma Community Advisory Board
Other Patient Councils, Advisory Boards or Panels
Patient representation in EMA drug approval processes
MPE Advocate Development Programme
MPE workshops, events and conferences
Other ways – I have other skills I would like to contribute!
*
Please, please tell us more below
Do you have any prior experience in these areas?
Please indicate all that apply (experience is absolutely not essential!)
Surveys around treatments, trials or around patient preferences
Reviewing materials designed for patients
Developing materials designed for patients
Workgroups, tasks or activities relating to Patient Engagement
Workgroup, tasks or activities relating to Clinical Research & Development
Workgroup, tasks or activities relating to Access to clinical trials and treatment
Myeloma Community Advisory Board
Other Patient Councils, Advisory Boards or Panels
Patient representation in EMA drug approval processes
MPE Advocate Development Programme
MPE workshops, events and conferences
Subscribe to our newsletter to stay informed on MPE news and activities?
*
Yes. Sign me up!
No, not right now
Click
here
to subscribe to our newsletter
*
I have read and I accept the
privacy policy
Our
privacy policy
tells you how we manage your submitted data.
CAPTCHA
Go to Top
I am a
*
Patient
Patient advocate
Caregiver
Doctor
Comments
This field is for validation purposes and should be left unchanged.
×